本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kura Oncology, Inc

6.03
+0.18003.08%
盘后:6.030.00000.00%19:21 EDT
成交量:399.50万
成交额:2,374.16万
市值:4.87亿
市盈率:-2.99
高:6.11
开:5.82
低:5.76
收:5.85
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2024/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/17

重要事件披露

Form 8-K - Current report
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

SEC问询函

Form CORRESP - Correspondence
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

SEC问询函

Form CORRESP - Correspondence
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”